New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted ...

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

Zai Lab presented updated Phase 1 data for ZL-1310, an investigational DLL3-targeted antibody-drug conjugate (ADC) for ...

Clinically meaningful anti-tumor activity of ZL-1310 observed ... and the potential treatment of SCLC and neuroendocrine tumors. These forward-looking statements may contain words such as ...

Beyond NEC, LBL-024 has shown encouraging early activity in other tumor types, including small cell lung cancer (SCLC), ovarian cancer (OC), biliary tract cancer (BTC), and with strong potential ...

3 DLL3 is an antigen overexpressed in many neuroendocrine tumors, such as SCLC, and is often associated ... called TMALIN®, which leverages the tumor microenvironment to overcome challenges ...

into a Phase 1 study in the U.S. DLL3 is upregulated in multiple solid tumor types, including small cell lung cancer (SCLC), neuroendocrine tumors (NETs), non-small cell lung cancer (NSCLC ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Meador: Small-cell lung cancer (SCLC) is an aggressive neuroendocrine cancer that accounts ... On gross examination, tumor deposits could be identified in numerous organs. The right lung was ...

SCLC starts in your lungs’ neuroendocrine cells ... When your body is exposed to constant hormones made by a tumor that started in your lungs, you can form Cushing syndrome.